Pancreatic Cancer Research

Clinical trialObservationalCompleted

INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors

Outcome
Finished, no results posted
Phase
Observational
Status
Completed
Study type
Observational
Start
2 February 2021
Ended
22 February 2025
Enrollment
342 participants
Sites
1
Primary outcomes
Relationship between known prognostic histological markers of pancreatic adenocarcinoma and patient survival.
Sponsor type
Academic / other
Results posted
No
Last update
30 March 2025

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The study is particularly innovative as it will accurately analyze the microscopic characteristics of the stroma, tumor budding and mucin expression in adenocarcinomas of the pancreas, using a comparative approach of long-survivor/short-survival patients.